
Cochrane Review of 17 Trials Found Anti-Amyloid Antibodies Made No Clinically Meaningful Difference in Early Alzheimer’s
TL;DR: A 2026 systematic review in The Cochrane Database of Systematic Reviews pooled 17 trials of anti-amyloid monoclonal antibodies (N=20,342 people with mild cognitive impairment or mild Alzheimer’s dementia) and concluded that any effect on memory decline…
Read article
